Analyst Recommendations

Benchmark analyst issues BUY recommendation for CHTR on February 5, 2024 12:58PM ET. The previous analyst recommendation was Buy.CHTR was trading at $307.545 at issue of the analyst...

February 5, 2024   CHTR -1.28%

Goldman Sachs analyst issues NEUTRAL recommendation for SAIA on February 5, 2024 02:32PM ET. The previous analyst recommendation was Neutral.SAIA was trading at $537.84 at issue of the...

February 5, 2024   SAIA 0.29%

Benchmark analyst issues BUY recommendation for CHTR on February 5, 2024 12:58PM ET. The previous analyst recommendation was Buy.CHTR was trading at $307.545 at issue of the analyst...

February 5, 2024   CHTR -1.28%

Benchmark analyst issues BUY recommendation for CHTR on February 5, 2024 12:58PM ET. The previous analyst recommendation was Buy.CHTR was trading at $307.545 at issue of the analyst...

February 5, 2024   CHTR -1.28%

Benchmark analyst issues BUY recommendation for CHTR on February 5, 2024 12:58PM ET. The previous analyst recommendation was Buy.CHTR was trading at $307.545 at issue of the analyst...

February 5, 2024   CHTR -1.28%

Mizuho Securities analyst issues BUY recommendation for CI on February 5, 2024 12:39PM ET. The previous analyst recommendation was Buy.CI was trading at $323.34 at issue of the...

February 5, 2024   CI -2.01%

Piper Sandler analyst issues OVERWEIGHT recommendation for TSLA on February 5, 2024 12:22PM ET. The previous analyst recommendation was Overweight.TSLA was trading at $181.5561 at issue of the...

February 5, 2024   TSLA 6.69%

Cowen & Co. analyst issues OUTPERFORM recommendation for MCD on February 5, 2024 11:13AM ET. The previous analyst recommendation was Outperform.MCD was trading at $285.1899 at issue of...

February 5, 2024   MCD -0.40%

Cowen & Co. analyst issues OUTPERFORM recommendation for MCD on February 5, 2024 11:13AM ET. The previous analyst recommendation was Outperform.MCD was trading at $285.1899 at issue of...

February 5, 2024   MCD -0.40%

Stephens analyst issues OVERWEIGHT recommendation for MCD on February 5, 2024 11:13AM ET. The previous analyst recommendation was Overweight.MCD was trading at $285.134 at issue of the analyst...

February 5, 2024   MCD -0.40%